VivoSim Labs (VIVS) Invested Capital (2012 - 2024)
VivoSim Labs (VIVS) posted quarterly Invested Capital of $353000.0 for Q4 2024, up 2253.33% quarter-over-quarter from $15000.0 in Q1 2014.
VivoSim Labs (VIVS) Invested Capital (2012 - 2024) Analysis & Trends
VivoSim Labs' Invested Capital history runs 3 years deep, the most recent figure standing at $353000.0 for Q4 2024.
- In Q4 2024, Invested Capital changed N/A year-over-year to $353000.0; the TTM figure through Sep 2025 stood at $353000.0 (changed N/A YoY), while the FY2014 annual figure was $15000.0, changed N/A from the prior year.
- Invested Capital for Q4 2024 stood at $353000.0, up from $15000.0 in the prior quarter.
- The five-year high for Invested Capital was $353000.0 in Q4 2024, with the low at $353000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 353,000.00 |
| Mar 31, 2014 | 15,000.00 |
| Sep 30, 2012 | 29,557.00 |